Discovery and Development of GSK3 Inhibitors for the Treatment of Type 2 Diabetes
Discovery and Development of GSK3 Inhibitors for the Treatment of Type 2 Diabetes
About this item
Full title
Author / Creator
Publisher
United Arab Emirates: Bentham Science Publishers Ltd
Journal title
Language
English
Formats
Publication information
Publisher
United Arab Emirates: Bentham Science Publishers Ltd
Subjects
More information
Scope and Contents
Contents
Originally identified as a modulator of glycogen metabolism, glycogen synthase kinase-3 (GSK3) is now understood to play an important regulatory role in a variety of pathways including initiation of protein synthesis, cell proliferation, cell differentiation, apoptosis, and is essential for embryonic development as a component of the Wnt signaling...
Alternative Titles
Full title
Discovery and Development of GSK3 Inhibitors for the Treatment of Type 2 Diabetes
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_71828017
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_71828017
Other Identifiers
ISSN
1381-6128
E-ISSN
1873-4286
DOI
10.2174/1381612043452668
